Is the US prepared to deal with another pandemic or widespread health crisis?
I will assess U.S. pandemic preparedness by reviewing recent official reports, expert analyses, and key readiness indicators from reliable sources.Gathering details from key recent reports on stockpiles, surveillance, funding, and remaining gaps.No, the US is better prepared than before COVID-19 in key areas but is not fully ready for another pandemic or widespread health crisis. Significant investments and reforms have closed some gaps exposed in 2020, yet recurring coordination problems, incomplete implementation of lessons, funding shortfalls, state-level disparities, supply chain vulnerabilities, and workforce/trust issues leave the country vulnerable. Assessments from the GAO, Bipartisan Commission on Biodefense, Trust for America’s Health (TFAH), CDC, WHO Joint External Evaluation (JEE), and administration reports consistently show progress alongside the need for sustained action.[1][2]
Improvements Since COVID-19
The US has strengthened several core capabilities:
These changes mean the US can detect some threats earlier, distribute countermeasures faster in many scenarios, and avoid some 2020-scale shortages of basic PPE.
Persistent Gaps and Challenges
Major shortcomings remain, and some recent trends (e.g., funding cliffs after COVID emergency funds expired) risk erosion:
WHO JEE overarching recommendations for the US emphasize better alignment of frameworks across jurisdictions/territories, extending capacities to SLTT levels, monitoring workforce investments, sustaining funding while reducing fragmentation/duplication, and building community trust/engagement.[7]
Bottom Line and Outlook
The US has stronger tools, stockpiles, surveillance, and institutional knowledge than in early 2020 and ranks relatively highly in global health security metrics. It handled aspects of later COVID phases, mpox, and other outbreaks more effectively in some respects. However, experts across bipartisan commissions, GAO, public health groups, and international evaluations agree it is not adequately prepared for a severe novel pandemic (especially a highly transmissible respiratory pathogen or one overwhelming hospitals/supply chains simultaneously with other disasters). Political will, sustained multi-year funding (beyond emergency spikes), full implementation of open recommendations, resilient domestic production, stronger SLTT integration, and public trust-building are essential. Threats like H5N1, mpox clade I, or unknown pathogens underscore the urgency—preparedness is an ongoing process, not a one-time fix. Continuous monitoring via tools like TFAH reports, GAO tracking, National Preparedness Reports, and JEEs will be key.
Citations (14)
- https://www.gao.gov/products/gao-24-107175
Backs: “vulnerable. Assessments from the GAO, Bipartisan Commission”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from the GAO, Bipartisan Commission on Biodefense, Trust for America’s Health (TFAH), CDC, WHO Joint External Evaluation (JEE), and administration reports consistently show progress alongside the need for sustained action.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “It has supported responses to H5N1 and other outbreaks. Investments continue in vaccines (including stockpiles and mRNA platforms adaptable for threats like H5N1), antivirals, diagnostics, and”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Over 80% of hospital EDs provide syndromic data. Wastewater surveillance, forecasting/modeling (via CDC’s Center for Forecasting and Outbreak Analytics), and integrated platforms (e.g., One CDC Data Platform) enable near real-time monitoring of respiratory illnesses and other threats.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2024/12/11/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report-demonstrating-the-impact-of-united-states-leadership-and-investments/
Backs: “Playbooks and response structures were used for mpox and other incidents. Global efforts include expanded part”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Strengths include nurse licensure compacts (41 states) and high rates of public health/emergency management accreditation. WHO’s 2024 JEE of the US (using a post-COVID tool) noted strong capacities in many of 19 technical areas, including laboratory systems, surveillance, and emergency response”
- https://www.who.int/publications/i/item/9789240105409
Backs: “WHO’s 2024 JEE of the US (using a post-COVID tool) noted strong capacities in many of 19 technical areas, including laboratory systems, surveillance, and emergency response operations, with overall high self-assessment scores in SPAR reporting.”
- https://extranet.who.int/sph/jee-united-states-america-conducted-0
Backs: “WHO’s 2024 JEE of the US (using a post-COVID tool) noted strong capacities in many of 19 technical areas, including laboratory systems, surveillance, and emergency response operations, with overall high self-assessment scores in S”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “Other advances: Faster vaccine/therapeutic development pathways (building on Operation Warp Speed lessons), equity-focused distribution models, and supply chain monitoring initiatives.”
- https://www.gao.gov/products/gao-24-106276
Backs: “HHS leadership/coordination of public health emergencies is still on GAO’s High-Risk List. The 2022–2023 mpox response repeated earlier challenges (vaccine/test access, coordination), highlighting the lack of a fully coordinated department-wide after-action process.”
- https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report
Backs: “BioWatch (airborne detection) remains ineffective after two decades. Coordination between federal, state, local, tribal, and territorial (SLTT) levels, plus public-private partners, still has ambiguities and turf issues.”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “Domestic manufacturing and resilient supply chains for PPE, pharmaceuticals, and APIs remain vulnerable to global disruptions, despite investments—stockpiles alone cannot fully substitute for surge capacity.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Responses to ongoing threats like H5N1 (avian influenza in cattle/poultry with limited human cases) have drawn criticism for insufficient urgency or application of COVID lessons.”
- https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca
Backs: “Responses to ongoing threats like H5N1 (avian influenza in cattle/poultry with limited human cases) have drawn criticism for insufficient urgency or application of COVID lessons. Potential policy shifts or cuts could further affect CDC/NIH biodefense focus, databases, or global engagement.”